Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
alirocumab
alnylam pharmaceuticals
amgen
biotech
boston blog main
boston top stories
brain
brain-computer interface
clinical trials
deals
elon musk
evolocumab
extreme
inclisiran
life sciences
medicine
national blog main
national top stories
neuralink
new york
new york blog main
new york top stories
novartis
pcsk9
pcsk9 inhibitors
regeneron pharmaceuticals
rna interference
sanofi
science
the medicines company
What
fda
3
×
new
wave
3
×
approval
cholesterol
drug
medicines
acquire
address
administration
advisory
agency
agreed
appeared
application
approving
attacks
billion
brain
brings
cardiovascular
cash
chip
claims
company
compound
deal
device
dozens
dramatically
elon
expects
extremetech
favor
food
greatly
health
heart
help
implantable
Language
unset
Current search:
wave
×
fda
×
@extremetech.com
1 year ago
FDA Reportedly Rejected Elon Musk’s Neuralink Brain Chip Trial Over Safety Risks
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@theverge.com
8 years ago
FDA panel recommends approving new drug that dramatically lowers cholesterol